Does TIRAGOLUMAB Cause Interstitial lung disease? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with TIRAGOLUMAB. This represents 1.1% of all adverse event reports for TIRAGOLUMAB.
6
Reports of Interstitial lung disease with TIRAGOLUMAB
1.1%
of all TIRAGOLUMAB reports
1
Deaths
6
Hospitalizations
How Dangerous Is Interstitial lung disease From TIRAGOLUMAB?
Of the 6 reports, 1 (16.7%) resulted in death, 6 (100.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRAGOLUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TIRAGOLUMAB Cause?
Off label use (58)
Hyperthyroidism (39)
Pneumonia (29)
Pneumonitis (26)
Infusion related reaction (23)
Intentional product use issue (23)
Death (21)
Adrenal insufficiency (20)
Troponin increased (20)
Colitis (15)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TIRAGOLUMAB Alternatives Have Lower Interstitial lung disease Risk?
TIRAGOLUMAB vs TIRBANIBULIN
TIRAGOLUMAB vs TIRZEPATIDE
TIRAGOLUMAB vs TISLELIZUMAB
TIRAGOLUMAB vs TISOTUMAB VEDOTIN
TIRAGOLUMAB vs TISOTUMAB VEDOTIN-TFTV